1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Perceptive Advisors Llc Buys Neurocrine Biosciences, Aclaris Therapeutics, Galapagos NV, Sells DexCom, Aerie Pharmaceuticals, Depomed

New York, NY, based Investment company Perceptive Advisors Llc buys Neurocrine Biosciences, Aclaris Therapeutics, Galapagos NV, Amicus Therapeutics, ANI Pharmaceuticals, Avadel Pharmaceuticals PLC, Acorda Therapeutics, AveXis, Global Blood Therapeutics, Ardelyx, sells DexCom, Aerie Pharmaceuticals, Depomed, Corbus Pharmaceuticals Holdings, Abiomed during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Perceptive Advisors Llc. As of 2016-12-31, Perceptive Advisors Llc owns 191 stocks with a total value of $1.4 billion. These are the details of the buys and sells.

For the details of PERCEPTIVE ADVISORS LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=PERCEPTIVE+ADVISORS+LLC

These are the top 5 holdings of PERCEPTIVE ADVISORS LLC
  1. Neurocrine Biosciences Inc (NBIX) - 3,316,523 shares, 9.2% of the total portfolio. Shares added by 33.93%
  2. Tesaro Inc (TSRO) - 687,993 shares, 6.63% of the total portfolio. Shares added by 0.82%
  3. Amicus Therapeutics Inc (FOLD) - 17,296,672 shares, 6.16% of the total portfolio. Shares added by 22.53%
  4. Sarepta Therapeutics Inc (SRPT) - 2,769,829 shares, 5.44% of the total portfolio. Shares reduced by 18.42%
  5. Versartis Inc (VSAR) - 4,153,685 shares, 4.43% of the total portfolio. Shares added by 3.10%
New Purchase: Galapagos NV (GLPG)

Perceptive Advisors Llc initiated holdings in Galapagos NV. The purchase prices were between $57.96 and $66.8, with an estimated average price of $61.54. The stock is now traded at around $82.29. The impact to the portfolio due to this purchase was 1.48%. The holdings were 304,531 shares as of 2016-12-31.

New Purchase: Avadel Pharmaceuticals PLC (AVDL)

Perceptive Advisors Llc initiated holdings in Avadel Pharmaceuticals PLC. The purchase prices were between $9.26 and $13.16, with an estimated average price of $10.99. The stock is now traded at around $9.73. The impact to the portfolio due to this purchase was 1.03%. The holdings were 1,388,240 shares as of 2016-12-31.

New Purchase: Acorda Therapeutics Inc (ACOR)

Perceptive Advisors Llc initiated holdings in Acorda Therapeutics Inc. The purchase prices were between $16.45 and $21.7, with an estimated average price of $19.81. The stock is now traded at around $27.00. The impact to the portfolio due to this purchase was 0.97%. The holdings were 720,000 shares as of 2016-12-31.

New Purchase: iRhythm Technologies Inc (IRTC)

Perceptive Advisors Llc initiated holdings in iRhythm Technologies Inc. The purchase prices were between $23.08 and $30.94, with an estimated average price of $26.94. The stock is now traded at around $35.86. The impact to the portfolio due to this purchase was 0.76%. The holdings were 352,241 shares as of 2016-12-31.

New Purchase: CytomX Therapeutics Inc (CTMX)

Perceptive Advisors Llc initiated holdings in CytomX Therapeutics Inc. The purchase prices were between $10.21 and $15.89, with an estimated average price of $12.12. The stock is now traded at around $19.00. The impact to the portfolio due to this purchase was 0.73%. The holdings were 923,763 shares as of 2016-12-31.

New Purchase: Biocryst Pharmaceuticals Inc (BCRX)

Perceptive Advisors Llc initiated holdings in Biocryst Pharmaceuticals Inc. The purchase prices were between $3.76 and $6.99, with an estimated average price of $5.2. The stock is now traded at around $9.14. The impact to the portfolio due to this purchase was 0.6%. The holdings were 1,330,240 shares as of 2016-12-31.

Added: Neurocrine Biosciences Inc (NBIX)

Perceptive Advisors Llc added to the holdings in Neurocrine Biosciences Inc by 33.93%. The purchase prices were between $37.9 and $54.77, with an estimated average price of $45.27. The stock is now traded at around $43.87. The impact to the portfolio due to this purchase was 2.33%. The holdings were 3,316,523 shares as of 2016-12-31.

Added: Aclaris Therapeutics Inc (ACRS)

Perceptive Advisors Llc added to the holdings in Aclaris Therapeutics Inc by 193.22%. The purchase prices were between $20.53 and $31.25, with an estimated average price of $25.5. The stock is now traded at around $28.76. The impact to the portfolio due to this purchase was 1.61%. The holdings were 1,260,847 shares as of 2016-12-31.

Added: Amicus Therapeutics Inc (FOLD)

Perceptive Advisors Llc added to the holdings in Amicus Therapeutics Inc by 22.53%. The purchase prices were between $4.53 and $9.35, with an estimated average price of $6.92. The stock is now traded at around $7.27. The impact to the portfolio due to this purchase was 1.13%. The holdings were 17,296,672 shares as of 2016-12-31.

Added: ANI Pharmaceuticals Inc (ANIP)

Perceptive Advisors Llc added to the holdings in ANI Pharmaceuticals Inc by 2210.35%. The purchase prices were between $47.51 and $68.96, with an estimated average price of $61.15. The stock is now traded at around $45.25. The impact to the portfolio due to this purchase was 1.11%. The holdings were 267,100 shares as of 2016-12-31.

Added: AveXis Inc (AVXS)

Perceptive Advisors Llc added to the holdings in AveXis Inc by 149.23%. The purchase prices were between $42 and $71.36, with an estimated average price of $53.44. The stock is now traded at around $79.73. The impact to the portfolio due to this purchase was 0.97%. The holdings were 473,531 shares as of 2016-12-31.

Added: Global Blood Therapeutics Inc (GBT)

Perceptive Advisors Llc added to the holdings in Global Blood Therapeutics Inc by 34.05%. The purchase prices were between $13.9 and $22.5, with an estimated average price of $17.57. The stock is now traded at around $37.40. The impact to the portfolio due to this purchase was 0.82%. The holdings were 3,128,978 shares as of 2016-12-31.

Sold Out: DexCom Inc (DXCM)

Perceptive Advisors Llc sold out the holdings in DexCom Inc. The sale prices were between $59.7 and $84.98, with an estimated average price of $70.86.

Sold Out: Depomed Inc (DEPO)

Perceptive Advisors Llc sold out the holdings in Depomed Inc. The sale prices were between $17.59 and $26.01, with an estimated average price of $21.23.

Sold Out: Achillion Pharmaceuticals Inc (ACHN)

Perceptive Advisors Llc sold out the holdings in Achillion Pharmaceuticals Inc. The sale prices were between $3.97 and $8.08, with an estimated average price of $5.32.

Sold Out: Proteostasis Therapeutics Inc (PTI)

Perceptive Advisors Llc sold out the holdings in Proteostasis Therapeutics Inc. The sale prices were between $6.87 and $15.67, with an estimated average price of $11.66.

Sold Out: Amarin Corp PLC (AMRN)

Perceptive Advisors Llc sold out the holdings in Amarin Corp PLC. The sale prices were between $2.75 and $3.47, with an estimated average price of $3.18.

Sold Out: Anthera Pharmaceuticals Inc (ANTH)

Perceptive Advisors Llc sold out the holdings in Anthera Pharmaceuticals Inc. The sale prices were between $0.65 and $3.32, with an estimated average price of $2.16.

Reduced: Aerie Pharmaceuticals Inc (AERI)

Perceptive Advisors Llc reduced to the holdings in Aerie Pharmaceuticals Inc by 87.71%. The sale prices were between $32.8 and $42.2, with an estimated average price of $37.82. The stock is now traded at around $48.20. The impact to the portfolio due to this sale was -0.89%. Perceptive Advisors Llc still held 50,000 shares as of 2016-12-31.

Reduced: Corbus Pharmaceuticals Holdings Inc (CRBP)

Perceptive Advisors Llc reduced to the holdings in Corbus Pharmaceuticals Holdings Inc by 58.06%. The sale prices were between $4.8 and $9.79, with an estimated average price of $7.64. The stock is now traded at around $10.35. The impact to the portfolio due to this sale was -0.7%. Perceptive Advisors Llc still held 1,132,684 shares as of 2016-12-31.

Reduced: Abiomed Inc (ABMD)

Perceptive Advisors Llc reduced to the holdings in Abiomed Inc by 99.83%. The sale prices were between $102.51 and $131.74, with an estimated average price of $115.85. The stock is now traded at around $123.59. The impact to the portfolio due to this sale was -0.53%. Perceptive Advisors Llc still held 109 shares as of 2016-12-31.

Reduced: Supernus Pharmaceuticals Inc (SUPN)

Perceptive Advisors Llc reduced to the holdings in Supernus Pharmaceuticals Inc by 99.83%. The sale prices were between $17.85 and $26.1, with an estimated average price of $22.34. The stock is now traded at around $29.83. The impact to the portfolio due to this sale was -0.4%. Perceptive Advisors Llc still held 421 shares as of 2016-12-31.

Reduced: Agenus Inc (AGEN)

Perceptive Advisors Llc reduced to the holdings in Agenus Inc by 91.98%. The sale prices were between $3.73 and $7.36, with an estimated average price of $5. The stock is now traded at around $4.09. The impact to the portfolio due to this sale was -0.39%. Perceptive Advisors Llc still held 72,187 shares as of 2016-12-31.

Reduced: Blueprint Medicines Corp (BPMC)

Perceptive Advisors Llc reduced to the holdings in Blueprint Medicines Corp by 40.48%. The sale prices were between $25.58 and $38.06, with an estimated average price of $30.14. The stock is now traded at around $41.34. The impact to the portfolio due to this sale was -0.36%. Perceptive Advisors Llc still held 273,820 shares as of 2016-12-31.



Here is the complete portfolio of PERCEPTIVE ADVISORS LLC. Also check out:

1. PERCEPTIVE ADVISORS LLC's Undervalued Stocks
2. PERCEPTIVE ADVISORS LLC's Top Growth Companies, and
3. PERCEPTIVE ADVISORS LLC's High Yield stocks
4. Stocks that PERCEPTIVE ADVISORS LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


GuruFocus has detected 3 Warning Signs with Neurocrine Biosciences Inc $NBIX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

User Generated Screeners


melblannHigh Quality
jan.ellsbergerDimaScreen
bennywangSelect
james scarrJames
worldmetalsHow to Find Good Dividend Stoc
Roger9860ubnt peers
Bogdan BednarskiShares Buyback W1 2007
Bogdan BednarskiShares Buyback W1 2006
jgmarisafricaAfrica
pbarker46Low short, low E10
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK